Fundamental Analysis
63 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +296.1% | +119.1% | 2 / 3 | +67.0% | +0.24 pp | +0.38 pp | +3.6% | 3.30 | 25.08 | 577 | +67,0% | 3,8 | +296,1% | 25.08 | 43.10 | −41,8% |
| Pts | 12 | 12 | 8 | 12 | 8 | 8 | 0 | -4 | 12 | |||||||
Valuation annotation:Price: 14.500 (close price on 2026-10-19)EPS (TTM): 578,2
Financial charts
1.Revenue & growth
VND bn577Q2/26
1.Revenue & growth
VND bn577Q2/26
2.Profit & growth
VND bn3,80Q2/26
3.Profit mix (Penman)
VND bn11,2Q2/26
4.Margins & cost structure
%6.6%Q2/26
5.Returns & cash cycle
% · days2.7%Q2/26
6.Earnings quality & cash
VND bn
7.Asset structure
VND bn1.851Q2/26
8.Funding & debt health
VND bn · times1.851Q2/26
9.Revenue backlog
VND bn325Q2/26
10.Valuation
times · %25,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %292Q2/26
Adjusted EPS growth, latest quarter
296%
Average adjusted EPS growth, 3 quarters
119%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26